Trial Profile

A retrospective evaluation of Extended-Release Topiramate (Trokendi XR) use in the real world clinical set up.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 30 Jul 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Topiramate (Primary)
Indications Epilepsy; Migraine; Obesity
Focus Adverse reactions; Therapeutic Use
Sponsors Supernus Pharmaceuticals

Most Recent Events

01 Jul 2018 Results (n=123) of post hoc analysis presented at the 60th Annual Scientific Meeting of the American Headache Society
01 Jul 2018 Results (n=159) of post hoc analysis evaluating patient characteristics associated with clinically significant response presented at the 60th Annual Scientific Meeting of the American Headache Society
03 May 2016 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com